- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | VITURA HEALTH LIMITED: Change of Address | - | ASX | ||
| 04.06. | VITURA HEALTH LIMITED: Appointment of Interim Chief Financial Officer | - | ASX | ||
| 04.06. | VITURA HEALTH LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 02.06. | VITURA HEALTH LIMITED: Chief Financial Officer Resignation | - | ASX | ||
| 26.05. | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX | ||
| 26.05. | VITURA HEALTH LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 20.05. | VITURA HEALTH LIMITED: Former CEO Legal Action Initiated | - | ASX | ||
| 27.04. | VITURA HEALTH LIMITED: Business Transformation Update | - | ASX | ||
| VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
| 21.04. | Vitura Health's Doctors on Demand on Track for Sustained Profitability as Consultations Surpass 1 Million | 1 | smallcaps.com.au | ||
| 20.04. | VITURA HEALTH LIMITED: Doctors on Demand Performance Update | - | ASX | ||
| 07.04. | VITURA HEALTH LIMITED: Final Director's Interest Notice | - | ASX | ||
| 07.04. | VITURA HEALTH LIMITED: Resignation of Non-Executive Director | - | ASX | ||
| 02.04. | VITURA HEALTH LIMITED: Appointment of Chief Executive Officer | - | ASX | ||
| 29.03. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 22.03. | VITURA HEALTH LIMITED: Cortexa advances commercialisation of MDMA supply | - | ASX | ||
| 17.03. | Vitura Health Signs Online Distribution Deal for MedReleaf Medicinal Cannabis Products | 2 | smallcaps.com.au | ||
| 16.03. | VITURA HEALTH LIMITED: VIT enters distribution agreement with MedReleaf Australia | - | ASX | ||
| 12.03. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: H1 FY26 Investor Presentation | 2 | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: H1 FY26 Results Release | 1 | ASX |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 2,372 | +0,08 % | Aurora Named to TIME Canada's Best Companies 2026 List | ||
| TILRAY BRANDS | 3,915 | +1,16 % | Tilray: Interview With Chairman & CEO Irwin Simon About The Diversified CPG Company | ||
| ORGANIGRAM GLOBAL | 0,822 | -2,61 % | Organigram Global Inc.: Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities | Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram") and Sanity Group GmbH ("Sanity" or "Sanity Group") jointly announced the successful closing of Organigram's previously... ► Artikel lesen | |
| SNDL | 1,129 | -0,53 % | 1CM Inc.: 1CM Provides Update on Arrangement Agreement with SNDL | Toronto, Ontario--(Newsfile Corp. - May 27, 2026) - 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") announces that it does not expect the proposed sale of its Ontario retail locations to... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 1,050 | +3,96 % | XFRA 0NF1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| WAYLAND GROUP | - | - | EQS-News: Berger Montague (Canada) PC: Ankündigung der Anhörung zur Genehmigung des Vergleichs - Wayland Group Corp., Scott Langille, Gerhard Müller, Paul Pathak, Eric Silver, M. Stein, John Does 1-3, Canaccord Genuity Corp. und RF Securities Clearing LP | EQS-News: Berger Montague (Canada) PC
/ Schlagwort(e): Rechtssache/Sonstiges
ANKÜNDIGUNG DER ANHÖRUNG ZUR GENEHMIGUNG DES VERGLEICHS - KURZFASSUNG - WAYLAND... ► Artikel lesen | |
| BIONANO GENOMICS | 1,200 | 0,00 % | Bionano Genomics: Bionano Announces Hiring of Chief Scientific Officer | SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D., as its Chief Scientific... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 11,225 | +2,14 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD) | HORIZON is a potentially pivotal, randomized, double-blind, placebo-controlled Phase 2 study evaluating TNX-102 SL (cyclobenzaprine HCl sublingual tablets) 5.6 mg as a first-line monotherapy in adults... ► Artikel lesen | |
| HIGH TIDE | 1,954 | +0,93 % | High Tide gibt die Einführung neuer Aktionärsrechtepläne bekannt | CALGARY, AB, 6. Juli 2026 / IRW-Press / High Tide Inc. ("High Tide" oder das "Unternehmen") (NASDAQ: HITI) (TSXV: HITI) (FWB: 2LYA), das
erfolgreiche, auf den Einzelhandel ausgerichtete Unternehmen... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 5,200 | -2,80 % | ACHIEVE LIFE SCIENCES, INC. - 8-K, Current Report | ||
| JAGUAR HEALTH | 2,290 | -0,87 % | Jaguar Health, Inc.: Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure | Company remains sharply focused on its ongoing global development program for crofelemer for rare IF diseasesNear-term milestones for IF program buttressed by continuing groundbreaking results of study... ► Artikel lesen | |
| GREENRISE GLOBAL BRANDS | 0,005 | -100,00 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| MEDIPHARM LABS | 0,040 | -11,11 % | MediPharm Labs Corp.: MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders | TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,026 | -26,09 % | ARGENT BIOPHARMA LIMITED: Application for quotation of securities - RGT | ||
| AYR WELLNESS | 0,050 | 0,00 % | Ayr Wellness Inc.: AYR Wellness Announces Closing of Exit Facility and Related Transactions | MIAMI, April 10, 2026 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, announces the initial... ► Artikel lesen |
Das Unternehmen VITURA HEALTH LIMITED kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,011 Euro. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,00 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITURA HEALTH LIMITED finden Sie auf Wallstreet Online.